Health Sciences Authority

Last updated
Health Sciences Authority
Health science authority Singapore.jpg
Health Sciences Authority logo.svg
Agency overview
Formed1 April 2001;23 years ago (2001-04-01)
Jurisdiction Government of Singapore
Headquarters11 Outram Road, Singapore 169078
Agency executives
  • Benjamin Ong Kian Chung, Chairman [1]
  • Mimi Choong May Ling, CEO [2]
Parent agency Ministry of Health
Website www.hsa.gov.sg

The Health Sciences Authority (HSA) is a statutory board under the Ministry of Health of the Government of Singapore. It is a multi-disciplinary agency responsible for applying medical, pharmaceutical, and scientific expertise to protect and advance public health and safety.

Contents

The organisation serves three key functions: it is the national regulator for health products; it secures the national blood supply through its operation of the national blood bank and management of transfusion medicine standards; and it represents the national expertise in forensic medicine, forensic science and analytical chemistry testing capabilities. These support other regulatory and compliance agencies in the administration of justice and in safeguarding public health. [2]

History

The Health Sciences Authority headquarters at Outram Road, Singapore. Health Sciences Authority 2008.jpg
The Health Sciences Authority headquarters at Outram Road, Singapore.

HSA was formed on 1 April 2001 with the integration of five specialised agencies under the Ministry of Health: the Centre for Drug Evaluation; Institute of Science and Forensic Medicine; National Pharmaceutical Administration; Product Regulation Department; and Singapore Blood Transfusion Service.

On 1 April 2019, HSA's food-related duties were absorbed by its successor Singapore Food Agency (SFA) which also absorbed the food-related duties of two other statutory boards namely Agri-Food and Veterinary Authority of Singapore (AVA) and National Environment Agency (NEA). SFA is a statutory board under the Ministry of the Environment and Water Resources. [3]

In February 2022, the HSA became the first regulatory authority in the world to attain the highest maturity level (ML 4) in the World Health Organization's classification of regulatory authorities for medical products. This affirms it as one of the leading regulators at ensuring the quality, safety and efficacy of medical products. [4]

Today, the agency comprises three professional groups: the Health Products Regulation Group; Blood Services Group, and Applied Sciences Group. Each group functions as Divisions comprising branches, units and laboratories. The three professional groups work with the Corporate Services Group which provides strategic direction and corporate support in advancing the organisation.

Role

Health products regulation

The Health Products Regulation Group ensures that medicines, innovative therapeutics, medical devices and health-related products are wisely regulated and meet appropriate safety, quality and efficacy standards. The agency also contributes to the development of biomedical sciences in Singapore by administering a robust, scientific and responsive regulatory framework.

HSA's risk management system takes into account pre-and-post market precautionary options. On the pre-market front, HSA administers clinical trials for new drugs and grants approvals for these products before they are marketed in Singapore. Audits on good manufacturing and distribution practices are also conducted. Regulation group would evaluate the medical device to determine whether it's acceptable to enter market. The medical device is classified as 4 levels according the product risk from Class A to Class D. [5]

On the post-market front, HSA monitors health products in the market through regular surveillance activities. The agency also carries out investigations and takes enforcement action against illegal activities related to unregistered, counterfeit and adulterated health products. HSA has an established and active pharmacovigilance programme that draws on its network of healthcare professionals and overseas regulators. This allows HSA to initiate targeted and prompt action in response to reported adverse drug reports and expedite the isolation of such problems and minimise harm to public health and safety.

In support of the national objective to reduce smoking, HSA enforces the laws that prohibit tobacco advertisements, smoking by youths under 21 years old as well as the sale of tobacco products to youths in this age group, as well as banning sales of emerging tobacco products such as hookah and electronic cigarettes.

National blood service

The Blood Services Group is the national blood service of Singapore and is responsible for the adequacy and safety of the country's blood supply. It runs the Bloodbank@HSA in Outram, as well as three satellite blood banks – Bloodbank@Woodlands, Bloodbank@DhobyGhaut and Bloodbank@WestgateTower – which collects, processes, tests and distributes blood and blood components to all hospitals in Singapore. The agency has established a framework to ensure that there is a steady supply of safe blood for day-to-day needs at hospitals and during emergencies. The framework covers the recruitment of voluntary non-remunerated blood donors, stringent blood donation screening criteria, a reliable battery of tests that is conducted on all collected blood, and a comprehensive quality system benchmarked against stringent internationally recognised standards.

The HSA has maintained a strategic partnership with the Singapore Red Cross since 2001 in managing the National Blood Donor Recruitment and Retention Programme.

The agency offers immunohaematology services and tissue typing services to local and regional healthcare institutions, as well as clinical consultative services in the specialty of transfusion medicine. In addition, the agency's cell therapy facility enables one-stop access to cell manufacturing and clinical trial implementation, blood processing and testing services.

Forensic and analytical sciences expertise

HSA's Applied Sciences Group represents Singapore's national expertise in forensic medicine, forensic sciences, analytical scientific capabilities as well as chemical metrology. This Group supports other regulatory and compliance agencies in the administration of justice and safeguarding public health. The Group comprises: Analytical Science (Chemical Metrology, Food Safety, and Pharmaceutical Divisions), Forensic Medicine and Forensic Science (Biology, Forensic Chemistry & Physics, Illicit Drugs and Analytical Toxicology Divisions).

The range of services cover forensic medical consultancy services in support of death investigation in Singapore; forensic science services such as criminalistics and DNA profiling in support of criminal investigations and illicit drugs control; analytical testing in support of health products regulation, cigarette and tobacco product control; water testing; and food safety testing. Toxicological services are also provided to hospitals.

In collaboration with the Agency for Science, Technology and Research (A*STAR), HSA has been a designated institute for chemical metrology in Singapore since 2008.

International alliances, affiliations and collaborative efforts

HSA has established strong collaborations through Memoranda of Understanding (MOU) with international partners. This is part of its commitment to enhance inter-agency regulatory efforts on the global front. Its international partners include agencies such as the US Food and Drug Administration, Health Canada, Swissmedic, the Australian Therapeutic Goods Administration and China Food and Drug Administration.

HSA's professional groups have been identified as WHO Collaborating Centres in three core areas of expertise - Transfusion Medicine, Drug Quality Assurance and Food Contaminants Monitoring. [6]

HSA has been internationally accredited by the AABB [7] (formerly known as the American Association of Blood Banks), and also the American Society of Histocompatibility & Immunogenetics. It is a founding member of the Asian Pacific Blood Network. As a WHO Collaborating Centre, the agency is an appointed Regional Quality Management Training Centre for Blood Transfusion Services.

It is the first agency outside of the United States of America to be accredited by the National Association of Medical Examiners (NAME), [8] and it also accredited by the American Society of Crime Laboratory Directors/Laboratory Accreditation Board, and the Singapore Laboratory Accreditation Scheme (SINGLAS).

The agency is also a United Nations International Drug Control Programme Reference Laboratory for Biological Specimens and Seized Materials.

Related Research Articles

<span class="mw-page-title-main">Food and Drug Administration</span> United States federal agency

The United States Food and Drug Administration is a federal agency of the Department of Health and Human Services. The FDA is responsible for protecting and promoting public health through the control and supervision of food safety, tobacco products, caffeine products, dietary supplements, prescription and over-the-counter pharmaceutical drugs (medications), vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices (ERED), cosmetics, animal foods & feed and veterinary products.

Transfusion medicine is the branch of medicine that encompasses all aspects of the transfusion of blood and blood components including aspects related to hemovigilance. It includes issues of blood donation, immunohematology and other laboratory testing for transfusion-transmitted diseases, management and monitoring of clinical transfusion practices, patient blood management, therapeutic apheresis, stem cell collections, cellular therapy, and coagulation. Laboratory management and understanding of state and federal regulations related to blood products are also a large part of the field.

<span class="mw-page-title-main">Good manufacturing practice</span> Manufacturing quality standards

Current good manufacturing practices (cGMP) are those conforming to the guidelines recommended by relevant agencies. Those agencies control the authorization and licensing of the manufacture and sale of food and beverages, cosmetics, pharmaceutical products, dietary supplements, and medical devices. These guidelines provide minimum requirements that a manufacturer must meet to assure that their products are consistently high in quality, from batch to batch, for their intended use. The rules that govern each industry may differ significantly; however, the main purpose of GMP is always to prevent harm from occurring to the end user. Additional tenets include ensuring the end product is free from contamination, that it is consistent in its manufacture, that its manufacture has been well documented, that personnel are well trained, and that the product has been checked for quality more than just at the end phase. GMP is typically ensured through the effective use of a quality management system (QMS).

The Medicines and Healthcare products Regulatory Agency (MHRA) is an executive agency of the Department of Health and Social Care in the United Kingdom which is responsible for ensuring that medicines and medical devices work and are acceptably safe.

The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) is an initiative that brings together regulatory authorities and pharmaceutical industry to discuss scientific and technical aspects of pharmaceutical product development and registration. The mission of the ICH is to promote public health by achieving greater harmonisation through the development of technical Guidelines and requirements for pharmaceutical product registration.

<span class="mw-page-title-main">National Medical Products Administration</span>

The National Medical Products Administration is a national bureau responsible for drug supervision under the State Council of China and is managed by the State Administration for Market Regulation.

In the experimental (non-clinical) research arena, good laboratory practice or GLP is a quality system of management controls for research laboratories and organizations to ensure the uniformity, consistency, reliability, reproducibility, quality, and integrity of products in development for human or animal health through non-clinical safety tests; from physio-chemical properties through acute to chronic toxicity tests.

The Center for Biologics Evaluation and Research (CBER) is one of six main centers for the U.S. Food and Drug Administration (FDA), which is a part of the U.S. Department of Health and Human Services. The current Director of CBER is Peter Marks, M.D., PhD. CBER is responsible for assuring the safety, purity, potency, and effectiveness of biologics and related products. Not all biologics are regulated by CBER. Monoclonal antibodies and other therapeutic proteins are regulated by the FDA Center for Drug Evaluation and Research (CDER).

<span class="mw-page-title-main">European Directorate for the Quality of Medicines & HealthCare</span> International organisation

The European Directorate for the Quality of Medicines & HealthCare (EDQM) is a Directorate of the Council of Europe that traces its origins and statutes to the Convention on the Elaboration of a European Pharmacopoeia.

<span class="mw-page-title-main">Food safety in China</span>

Food safety in China is a widespread concern for the country's agricultural industry. China's principal crops are rice, corn, wheat, soybeans, and cotton in addition to apples and other fruits and vegetables. China's principal livestock products include pork, beef, dairy, and eggs. The Chinese government oversees agricultural production as well as the manufacture of food packaging, containers, chemical additives, drug production, and business regulation. In recent years, the Chinese government attempted to consolidate food safety regulation with the creation of the State Food and Drug Administration of China in 2003; officials have also been under increasing public and international pressure to solve food safety problems. Chinese Vice Premier Li Keqiang said, "Food is essential, and safety should be a top priority. Food safety is closely related to people's lives and health and economic development and social harmony," at a State Council meeting in Beijing.

<span class="mw-page-title-main">Office of Global Regulatory Operations and Policy</span>

The Office of Global Regulatory Operations and Policy (GO), also known as the Office of Regulatory Affairs (ORA), is the part of the U.S. Food and Drug Administration (FDA) enforcing the federal laws governing biologics, cosmetics, dietary supplements, drugs, food, medical devices, radiation-emitting electronic devices, tobacco products, and veterinary medicine products which may have potentially harmful side effects for the consumer.

The South African National Accreditation System (SANAS) is the official accreditation body for South Africa. Founded in 1996, SANAS is headquartered in Pretoria, South Africa. SANAS accreditation certificates are a formal recognition by the Government of South Africa that an organisation is competent to perform specific tasks.

<span class="mw-page-title-main">Medical laboratory</span> Principles of management with special reference to medical science

A medical laboratory or clinical laboratory is a laboratory where tests are conducted out on clinical specimens to obtain information about the health of a patient to aid in diagnosis, treatment, and prevention of disease. Clinical medical laboratories are an example of applied science, as opposed to research laboratories that focus on basic science, such as found in some academic institutions.

Verification and validation are independent procedures that are used together for checking that a product, service, or system meets requirements and specifications and that it fulfills its intended purpose. These are critical components of a quality management system such as ISO 9000. The words "verification" and "validation" are sometimes preceded with "independent", indicating that the verification and validation is to be performed by a disinterested third party. "Independent verification and validation" can be abbreviated as "IV&V".

Regulatory science is the scientific and technical foundations upon which regulations are based in various industries – particularly those involving health or safety. Regulatory bodies employing such principles in the United States include, for example, the FDA for food and medical products, the EPA for the environment, and the OSHA for work safety.

<span class="mw-page-title-main">Pharmaceuticals and Medical Devices Agency</span> Japanese Independent Administrative Institution

The Pharmaceuticals and Medical Devices Agency (PhMDA) is an Independent Administrative Institution responsible for ensuring the safety, efficacy and quality of pharmaceuticals and medical devices in Japan. It is similar in function to the Food and Drug Administration in the United States, the Medicines and Healthcare products Regulatory Agency in the United Kingdom, the Spanish Agency of Medicines and Medical Devices in Spain or the Food and Drug Administration in the Philippines.

<span class="mw-page-title-main">Food and Drug Administration (Philippines)</span> Government agency

The Food and Drug Administration (FDA) of the Philippines, formerly the Bureau of Food and Drugs, is a health regulatory agency under the Department of Health created on 1963 by Republic Act No. 3720, amended on 1987 by Executive Order 175 otherwise known as the “Food, Drugs and Devices, and Cosmetics Act”, and subsequently reorganized by Republic Act No. 9711 otherwise known as “The Food and Drug Administration Act of 2009”. The agency is responsible for licensing, monitoring, and regulation of cosmetics, drugs, foods, household hazardous products, medical devices and electromagnetic radiation emitting devices, pesticides, tobacco and related products, and vaccines for safety, efficacy, and quality in the Republic of the Philippines.

A certificate of analysis (COA) is a formal laboratory-prepared document that details the results of one or more laboratory analyses, signed—manually or electronically—by an authorized representative of the entity conducting the analyses. This document gives assurances to the recipient that the analyzed item is what it is designated to be, or has the features advertised by the producer. The design and content of a COA may be based upon a set of requirements identified by the lab, by regulatory-driven requirements, and/or by standards developed by standard developing organizations. The COA is used in a wide variety of industries, including but not limited to the agriculture, chemical, clinical research, food and beverage, and pharmaceutical industries.

The International Coalition of Medicines Regulatory Authorities (ICMRA) is a global conference of government health bureaucrats.

References

  1. "Appointment of new Chairman for Health Sciences Authority". MOH. 23 September 2021. Retrieved 25 September 2021.
  2. 1 2 "About HSA". Health Sciences Authority. Archived from the original on 10 July 2022. Retrieved 10 July 2022.
  3. "New stat board to oversee food safety and security; AVA to be disbanded". CNA. Archived from the original on 2019-04-03. Retrieved 2018-07-26.
  4. "Singapore medicines regulator world's first to achieve highest maturity level in WHO classification". World Health Organization. 27 February 2022. Archived from the original on 10 July 2022. Retrieved 10 July 2022.
  5. "新加坡醫療器材註冊介紹". July 21, 2020.
  6. "HSA Pharmaceutical Laboratory Designated a World Health Organisation Prequalified Quality Control Laboratory in Pharmaceuticals". HSA. 3 July 2009. Retrieved 2020-11-19.
  7. "Singapore". www.aabb.org. Retrieved 2020-11-19.
  8. "ANNUAL REPORT 2017/18" (PDF). Health Sciences Authority. Retrieved 2020-11-19.